849 results on '"Rakela, Jorge"'
Search Results
152. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome
153. Monoclonal Gammopathy of Undetermined Significance Does Not Affect Outcomes in Patients Undergoing Solid Organ Transplants
154. Mo1495 Anastomotic Biliary Strictures After Living Donor Liver Transplant: Ischemia Increases Recurrence Following Initial Endoscopic Treatment
155. Role of Antibiotics Use in Patients with Cirrhosis and Acute Variceal Bleeding: Single Center Experience
156. Gene therapy and enhancement for diabetes (and other diseases): the multiplicity of considerations
157. Treatment of Hepatitis C in Renal Transplantation Candidates: A Single-Center Experience
158. Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates
159. Short-Term Cardiac and Noncardiac Mortality Following Liver Transplantation
160. Severe Hepatotoxicity Caused by a Methasteron-containing Performance-enhancing Supplement
161. W1875 Erythropoietin Use in Patients On Chronic Hepatitis C Treatment: Incidence of Thromboembolic Events and Hepatocellular Carcinoma
162. Screening for Esophageal Varices in End Stage Liver Disease: Utility of Esophageal Capsule Endoscopy
163. T1949 Role of Magnetic Resonance Elastography to Assess Hepatic Fibrosis
164. Contributors
165. Conflict of interest policy
166. Applicability of Capsule Endoscopy in Screening for Portal Hypertension
167. Faculty Opinions recommendation of Hepatitis C virus load and survival among injection drug users in the United States.
168. Faculty Opinions recommendation of Refractory ascites after liver transplantation: an analysis of 1058 liver transplant patients at a single center.
169. Faculty Opinions recommendation of Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation.
170. Faculty Opinions recommendation of Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.
171. Artificial Neural Network and Tissue Genotyping of Hepatocellular Carcinoma in Liver-Transplant Recipients: Prediction of Recurrence
172. Management of pre-liver transplantation patient?Part 2
173. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
174. Management of pre-liver transplantation patients?Part 1
175. Hepatitis C Virus Infection with Hepatocellular Carcinoma: Not A Controversial Indication for Liver Transplantation
176. A message from the incoming editors ofLiver Transplantation
177. Liver transplantation for hepatocellular carcinoma: The MELD impact
178. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-α and interleukin 8
179. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1
180. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation
181. Steatosis in hepatitis C genotype 3 is associated with intravenous drug abuse and not with fibrosis
182. Association of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and primary sclerosing cholangitis (PSC)
183. Impact of hepatitis B and hepatitis C on solid organ transplantation
184. Detection and Analysis of Hepatitis C Virus Sequences in Cerebrospinal Fluid
185. The long-term outcome of liver transplant recipients with de novo hepatitis B infection who received an anti-HBC graft
186. Search for Hepatitis C Virus Negative-Strand RNA Sequences and Analysis of Viral Sequences in the Central Nervous System: Evidence of Replication
187. CHANGES IN HEPATITIS C VIRUS POPULATION IN SERUM AND PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONICALLY INFECTED PATIENTS RECEIVING LIVER GRAFT FROM INFECTED DONORS
188. Pre-transplant psychiatric disorders affect length of stay and mortality in liver transplantion
189. Mayo end-stage liver disease (MELD) score: Causes of variablitity in patients with end-stage liver disease (ESLD)
190. Increased prevelance of osteoporosis in patients with end-stage liver diseasse secondary to hepatitis C infection and alcohol
191. Exposure of Hepatitis C Virus (HCV) RNA-Positive Recipients to HCV RNA-Positive Blood Donors Results in Rapid Predominance of a Single Donor Strain and Exclusion and/or Suppression of the Recipient Strain
192. Exposure of Hepatitis C Virus–Negative Recipients to ⩾2 Infected Blood Donors
193. The effect of orthotopic liver transplantation on the QTc interval in patients with end-stage liver disease
194. A classic presentation of Allagile's syndrome with rarely described anomaly of aortic stenosis
195. REMOTE CONTROL: OUTCOMES UTILIZING TELEMEDICINE FOR OFF-SITE PRE-TRANSPLANT EVALUATION AND POST-TRANSPLANT LONG-TERM CARE.
196. A randomized, double blind, placebo controlled trial of interferon-alfa and amantadine versus interferon-alfa alone in the treatment of chronic hepatitis C
197. Hepatitis C related cardiomyopathy: Fact or fiction?
198. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria
199. LATE-ONSET RENAL FAILURE AFTER LIVER TRANSPLANTATION: ROLE OF POSTTRANSPLANT ALCOHOL USE1
200. Hepatitis C Virus in Lymphoid Cells of Patients Coinfected with Human Immunodeficiency Virus Type 1: Evidence of Active Replication in Monocytes/Macrophages and Lymphocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.